"kissei" - Google News

Update: Reversal after 20 deaths allows new Japan patients to take Amgen's rare disease drug Tavneos - BioSpace

Thu, 21 May 2026 07:00:00 GMT

Update: Reversal after 20 deaths allows new Japan patients to take Amgen's rare disease drug Tavneos BioSpace

Assessing Whether Kissei Pharmaceutical (TSE:4547) Looks Undervalued After Recent Share Price Weakness - simplywall.st

Wed, 03 Jun 2026 23:39:32 GMT

Assessing Whether Kissei Pharmaceutical (TSE:4547) Looks Undervalued After Recent Share Price Weakness simplywall.st

Amgen's rare disease drug linked to deaths, liver injuries in Japan, Kissei reports - Reuters

Fri, 15 May 2026 07:00:00 GMT

Amgen's rare disease drug linked to deaths, liver injuries in Japan, Kissei reports Reuters

Amgen's Tavneos, facing liver injury scrutiny, gets label update in Japan as patient starts resume - Fierce Pharma

Thu, 21 May 2026 07:00:00 GMT

Amgen's Tavneos, facing liver injury scrutiny, gets label update in Japan as patient starts resume Fierce Pharma

20 deaths: Kissei Pharmaceutical urges doctors to halt Tavneos use - 朝日新聞

Mon, 18 May 2026 07:00:00 GMT

20 deaths: Kissei Pharmaceutical urges doctors to halt Tavneos use 朝日新聞

Kissei ordered to add warning over vasculitis drug after fatalities - The Japan Times

Fri, 22 May 2026 07:00:00 GMT

Kissei ordered to add warning over vasculitis drug after fatalities The Japan Times

Kissei pays Viridian $70M to challenge Amgen for Japanese eye disease market - Fierce Biotech

Wed, 30 Jul 2025 07:00:00 GMT

Kissei pays Viridian $70M to challenge Amgen for Japanese eye disease market Fierce Biotech

Jefferies Adjusts Kissei Pharmaceutical's Price Target to 4,800 Yen From 5,400 Yen, Keeps at Buy - Moomoo

Mon, 25 May 2026 07:00:00 GMT

Jefferies Adjusts Kissei Pharmaceutical's Price Target to 4,800 Yen From 5,400 Yen, Keeps at Buy Moomoo

Kissei Pharmaceutical Co - Currently Examining Financial Impact Of Rapid Safety Communication Regarding Tavneos (Generic Name Avacopan) - TradingView

Wed, 20 May 2026 07:00:00 GMT

Kissei Pharmaceutical Co - Currently Examining Financial Impact Of Rapid Safety Communication Regarding Tavneos (Generic Name Avacopan) TradingView

Kissei Urges Tavneos Caution In Japan After 20 Deaths - Citeline News & Insights

Sun, 17 May 2026 07:00:00 GMT

Kissei Urges Tavneos Caution In Japan After 20 Deaths Citeline News & Insights

Amgen stock falls after Kissei warns on Tavneos liver risks - Investing.com

Fri, 15 May 2026 07:00:00 GMT

Amgen stock falls after Kissei warns on Tavneos liver risks Investing.com

Amgen’s Tavneos Discouraged by Japanese Partner After Deaths - Bloomberg.com

Fri, 15 May 2026 07:00:00 GMT

Amgen’s Tavneos Discouraged by Japanese Partner After Deaths Bloomberg.com

Rigel (RIGL) Gains Momentum as Kissei Submits NDA for Rezlidhia in Japan - GuruFocus

Wed, 27 May 2026 07:00:00 GMT

Rigel (RIGL) Gains Momentum as Kissei Submits NDA for Rezlidhia in Japan GuruFocus

20 People in Japan Died After Taking Amgen Drug - WSJ

Fri, 15 May 2026 07:00:00 GMT

20 People in Japan Died After Taking Amgen Drug WSJ

Viridian Therapeutics and Kissei Pharmaceutical Enter $70 Million Collaboration and License Agreement to Develop Veligrotug & VRDN-003 - Pharmaceutical Executive

Thu, 31 Jul 2025 07:00:00 GMT

Viridian Therapeutics and Kissei Pharmaceutical Enter $70 Million Collaboration and License Agreement to Develop Veligrotug & VRDN-003 Pharmaceutical Executive

Japan restores new patient access to Tavneos with tougher warnings - The Pharma Letter

Fri, 22 May 2026 07:00:00 GMT

Japan restores new patient access to Tavneos with tougher warnings The Pharma Letter

Viridian partners with Kissei Pharmaceutical to advance thyroid eye disease therapies in Japan - Optometry Times

Mon, 04 Aug 2025 07:00:00 GMT

Viridian partners with Kissei Pharmaceutical to advance thyroid eye disease therapies in Japan Optometry Times

Amgen’s Tavneos discouraged by Japanese partner after deaths - The Japan Times

Sat, 16 May 2026 07:00:00 GMT

Amgen’s Tavneos discouraged by Japanese partner after deaths The Japan Times

Kissei Pharmaceutical's (TSE:4547) Solid Earnings May Rest On Weak Foundations - simplywall.st

Mon, 18 May 2026 07:00:00 GMT

Kissei Pharmaceutical's (TSE:4547) Solid Earnings May Rest On Weak Foundations simplywall.st

Apotex Strengthens Commitment to Women's Health with Exclusive Canadian Rights to "Linzagolix" for Uterine Fibroid Treatment - PR Newswire

Tue, 07 Oct 2025 07:00:00 GMT

Apotex Strengthens Commitment to Women's Health with Exclusive Canadian Rights to "Linzagolix" for Uterine Fibroid Treatment PR Newswire

20 Deaths in Japan Reported after Use of Kissei Pharmaceutical Vasculitis Drug; Company Urges Suspension of New Prescriptions - The Japan News

Sun, 17 May 2026 07:00:00 GMT

20 Deaths in Japan Reported after Use of Kissei Pharmaceutical Vasculitis Drug; Company Urges Suspension of New Prescriptions The Japan News

Japan drugmaker urges doctors not to use kidney disease med Tavneos for new patients - 毎日新聞

Sat, 16 May 2026 07:00:00 GMT

Japan drugmaker urges doctors not to use kidney disease med Tavneos for new patients 毎日新聞

Amgen Japanese Partner Urges Caution On Tavneos Use - Yahoo Finance

Mon, 18 May 2026 07:00:00 GMT

Amgen Japanese Partner Urges Caution On Tavneos Use Yahoo Finance

Viridian finds Japanese partner for promising eye disease candidates - FirstWord Pharma

Wed, 30 Jul 2025 07:00:00 GMT

Viridian finds Japanese partner for promising eye disease candidates FirstWord Pharma

Amgen’s Tavneos reportedly linked to 20 deaths in Japan - Seeking Alpha

Sat, 16 May 2026 07:00:00 GMT

Amgen’s Tavneos reportedly linked to 20 deaths in Japan Seeking Alpha

Japan pharma firm warns against rare diseases drug after deaths - The Manila Times

Sun, 17 May 2026 07:00:00 GMT

Japan pharma firm warns against rare diseases drug after deaths The Manila Times

Rigel Expands Relationship with Kissei to include REZLIDHIA® (olutasidenib) in Japan, the Republic of Korea and Taiwan - PR Newswire

Tue, 03 Sep 2024 07:00:00 GMT

Rigel Expands Relationship with Kissei to include REZLIDHIA® (olutasidenib) in Japan, the Republic of Korea and Taiwan PR Newswire

Kissei Pharmaceutical stock (JP3212800001): Announces 1.3M Share Buyback - AD HOC NEWS

Tue, 12 May 2026 07:00:00 GMT

Kissei Pharmaceutical stock (JP3212800001): Announces 1.3M Share Buyback AD HOC NEWS

20 patients die after receiving vasculitis drug Tavneos - Tuoi Tre News | The News Gateway to Vietnam

Tue, 19 May 2026 07:00:00 GMT

20 patients die after receiving vasculitis drug Tavneos Tuoi Tre News | The News Gateway to Vietnam

Kissei Antonio - CitiNewsroom.com

Fri, 15 May 2026 17:27:18 GMT

Kissei Antonio CitiNewsroom.com

JW Pharm acquires rights for Kissei Pharmaceutical's uterine fibroid treatment - koreabiomed.com

Mon, 10 Jun 2024 07:00:00 GMT

JW Pharm acquires rights for Kissei Pharmaceutical's uterine fibroid treatment koreabiomed.com

Kissei Pharmaceutical discovers new TSHR antagonists - BioWorld News

Wed, 24 Jan 2024 08:00:00 GMT

Kissei Pharmaceutical discovers new TSHR antagonists BioWorld News

Kissei Pharmaceutical stock (JP3212800001): Tavneos safety alert in Japan draws global investor focu - AD HOC NEWS

Sat, 16 May 2026 07:00:00 GMT

Kissei Pharmaceutical stock (JP3212800001): Tavneos safety alert in Japan draws global investor focu AD HOC NEWS

Kissei Pharmaceutical presents new orexin OX2 receptor agonists for narcolepsy - BioWorld News

Wed, 08 May 2024 07:00:00 GMT

Kissei Pharmaceutical presents new orexin OX2 receptor agonists for narcolepsy BioWorld News

Rigel Pharmaceuticals Enters Collaboration and License Agreement with Kissei Pharmaceutical Co., Ltd. to Develop and Commercialize TAVALISSE™ (fostamatinib disodium hexahydrate) in Japan and other Asian Countries - PR Newswire

Mon, 29 Oct 2018 07:00:00 GMT

Rigel Pharmaceuticals Enters Collaboration and License Agreement with Kissei Pharmaceutical Co., Ltd. to Develop and Commercialize TAVALISSE™ (fostamatinib disodium hexahydrate) in Japan and other Asian Countries PR Newswire

Safety Research Laboratories | Research & Development | English Home | KISSEI PHARMACEUTICAL CO.,LTD. - kissei.co.jp

Mon, 15 Jan 2018 17:05:35 GMT

Safety Research Laboratories | Research & Development | English Home | KISSEI PHARMACEUTICAL CO.,LTD. kissei.co.jp

4547 Stock Price and Chart — TSE:4547 - TradingView

Sat, 05 Aug 2017 20:14:28 GMT

4547 Stock Price and Chart — TSE:4547 TradingView

Kissei Pharmaceutical Sets Share Buyback Framework but Executes No Purchases in May - TipRanks

Wed, 03 Jun 2026 07:00:39 GMT

Kissei Pharmaceutical Sets Share Buyback Framework but Executes No Purchases in May TipRanks

Kissei Files Japan NDA for IDH1-Targeting AML Drug Olutasidenib - TipRanks

Wed, 27 May 2026 07:00:00 GMT

Kissei Files Japan NDA for IDH1-Targeting AML Drug Olutasidenib TipRanks

Kissei Tightens Safety Warnings on TAVNEOS After Serious Liver Risk Cases - TipRanks

Wed, 20 May 2026 07:00:00 GMT

Kissei Tightens Safety Warnings on TAVNEOS After Serious Liver Risk Cases TipRanks

Kissei Pharmaceutical’s Avacopan Study: A Potential Game-Changer for Autoimmune Treatments - TipRanks

Mon, 27 Oct 2025 07:00:00 GMT

Kissei Pharmaceutical’s Avacopan Study: A Potential Game-Changer for Autoimmune Treatments TipRanks

Japan reports 20 deaths in patients taking Tavneos ᐉ News from Fakti.bg - Здраве - Fakti.bg

Sat, 16 May 2026 02:59:31 GMT

Japan reports 20 deaths in patients taking Tavneos ᐉ News from Fakti.bg - Здраве Fakti.bg